nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—Betamethasone—hematologic cancer	0.134	0.632	CbGbCtD
Carbimazole—CYP19A1—Dexamethasone—hematologic cancer	0.0778	0.368	CbGbCtD
Carbimazole—CYP19A1—ovarian follicle—hematologic cancer	0.0475	0.485	CbGeAlD
Carbimazole—TPO—hematopoietic system—hematologic cancer	0.0201	0.205	CbGeAlD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—LMO2—hematologic cancer	0.0164	0.074	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CBFA2T3—hematologic cancer	0.0125	0.0561	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—LYL1—hematologic cancer	0.0125	0.0561	CbGpPWpGaD
Carbimazole—TPO—testis—hematologic cancer	0.011	0.113	CbGeAlD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—GYPA—hematologic cancer	0.0106	0.0477	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—SPI1—hematologic cancer	0.00715	0.0322	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IKZF1—hematologic cancer	0.00715	0.0322	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—ALK—hematologic cancer	0.00652	0.0294	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—GATA2—hematologic cancer	0.0063	0.0284	CbGpPWpGaD
Carbimazole—CYP19A1—hematopoietic system—hematologic cancer	0.00574	0.0585	CbGeAlD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—GATA1—hematologic cancer	0.00542	0.0244	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—RUNX1—hematologic cancer	0.00496	0.0223	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF3—hematologic cancer	0.00446	0.0201	CbGpPWpGaD
Carbimazole—CYP19A1—gonad—hematologic cancer	0.00436	0.0445	CbGeAlD
Carbimazole—TPO—Differentiation Pathway—CSF1R—hematologic cancer	0.00398	0.0179	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF1—hematologic cancer	0.00396	0.0179	CbGpPWpGaD
Carbimazole—CYP19A1—blood—hematologic cancer	0.0038	0.0388	CbGeAlD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—MYB—hematologic cancer	0.00362	0.0163	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—CSF1—hematologic cancer	0.00343	0.0154	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—TNFSF11—hematologic cancer	0.00325	0.0146	CbGpPWpGaD
Carbimazole—CYP19A1—testis—hematologic cancer	0.00314	0.0321	CbGeAlD
Carbimazole—TPO—Differentiation Pathway—DKK1—hematologic cancer	0.00295	0.0133	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—EPO—hematologic cancer	0.00274	0.0124	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—FTCD—hematologic cancer	0.00274	0.0123	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CXCR4—hematologic cancer	0.00255	0.0115	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL3—hematologic cancer	0.00246	0.0111	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—EPO—hematologic cancer	0.00237	0.0107	CbGpPWpGaD
Carbimazole—CYP19A1—lymph node—hematologic cancer	0.00228	0.0233	CbGeAlD
Carbimazole—TPO—Amino acid and derivative metabolism—ASNS—hematologic cancer	0.00219	0.00986	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL3—hematologic cancer	0.00213	0.00959	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—KITLG—hematologic cancer	0.00211	0.00949	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—HDC—hematologic cancer	0.00207	0.00934	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—SGK1—hematologic cancer	0.00207	0.00932	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—STAT5A—hematologic cancer	0.00206	0.00928	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF2—hematologic cancer	0.00191	0.00862	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—PDGFA—hematologic cancer	0.00185	0.00832	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—KITLG—hematologic cancer	0.00182	0.0082	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—HGF—hematologic cancer	0.00167	0.00754	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—FGF1—hematologic cancer	0.00165	0.00745	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—MTAP—hematologic cancer	0.00161	0.00727	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—hematologic cancer	0.00147	0.00662	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—PDGFB—hematologic cancer	0.00144	0.00648	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—FOS—hematologic cancer	0.00137	0.00617	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—NOTCH1—hematologic cancer	0.00127	0.00572	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—EIF4EBP1—hematologic cancer	0.00125	0.00565	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—KIT—hematologic cancer	0.00124	0.0056	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6R—hematologic cancer	0.00115	0.0052	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—MLH1—hematologic cancer	0.00109	0.00493	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—FGF2—hematologic cancer	0.00105	0.00471	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—hematologic cancer	0.00102	0.00457	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—MTR—hematologic cancer	0.000926	0.00417	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CCND2—hematologic cancer	0.000829	0.00374	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—FOXO1—hematologic cancer	0.000787	0.00355	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—hematologic cancer	0.000743	0.00335	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—NQO1—hematologic cancer	0.000732	0.0033	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAK1—hematologic cancer	0.000718	0.00324	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—NCOR1—hematologic cancer	0.000705	0.00318	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—TGFB1—hematologic cancer	0.000682	0.00307	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—TSC2—hematologic cancer	0.000679	0.00306	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK14—hematologic cancer	0.000647	0.00291	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—hematologic cancer	0.000594	0.00268	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—SLC35B2—hematologic cancer	0.000577	0.0026	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—CREB1—hematologic cancer	0.000571	0.00257	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—EPHX1—hematologic cancer	0.000569	0.00256	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—ATM—hematologic cancer	0.000559	0.00252	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDK4—hematologic cancer	0.000556	0.00251	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6—hematologic cancer	0.000514	0.00232	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GMPS—hematologic cancer	0.000502	0.00226	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FTCD—hematologic cancer	0.000502	0.00226	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PHYH—hematologic cancer	0.000502	0.00226	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ATR—hematologic cancer	0.000485	0.00219	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MTOR—hematologic cancer	0.00046	0.00207	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SMPD3—hematologic cancer	0.00046	0.00207	CbGpPWpGaD
Carbimazole—TPO—Metabolism—B3GAT1—hematologic cancer	0.000402	0.00181	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ASNS—hematologic cancer	0.000402	0.00181	CbGpPWpGaD
Carbimazole—TPO—Metabolism—DCK—hematologic cancer	0.000402	0.00181	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NF1—hematologic cancer	0.000396	0.00178	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HDC—hematologic cancer	0.000381	0.00172	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDKN1B—hematologic cancer	0.000377	0.0017	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTO1—hematologic cancer	0.000372	0.00168	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—SRC—hematologic cancer	0.000368	0.00166	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTO1—hematologic cancer	0.000367	0.00165	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—UGT1A1—hematologic cancer	0.00035	0.00158	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CDA—hematologic cancer	0.000348	0.00157	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NCOA3—hematologic cancer	0.000346	0.00156	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—UGT1A1—hematologic cancer	0.000345	0.00155	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.000344	0.00155	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK3—hematologic cancer	0.000339	0.00153	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PC—hematologic cancer	0.000335	0.00151	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PML—hematologic cancer	0.000328	0.00148	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—hematologic cancer	0.000328	0.00148	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GBA—hematologic cancer	0.000324	0.00146	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC35B2—hematologic cancer	0.000324	0.00146	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.000314	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—MDM2—hematologic cancer	0.000308	0.00139	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—MTR—hematologic cancer	0.000303	0.00137	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTAP—hematologic cancer	0.000296	0.00133	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTT1—hematologic cancer	0.000288	0.0013	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FHL2—hematologic cancer	0.000264	0.00119	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AGRN—hematologic cancer	0.000259	0.00117	CbGpPWpGaD
Carbimazole—TPO—Metabolism—IDH2—hematologic cancer	0.000245	0.00111	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMMR—hematologic cancer	0.000245	0.00111	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—STAT1—hematologic cancer	0.000241	0.00109	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AR—hematologic cancer	0.000233	0.00105	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ARNTL—hematologic cancer	0.000231	0.00104	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—hematologic cancer	0.000229	0.00103	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ACP5—hematologic cancer	0.000224	0.00101	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CA9—hematologic cancer	0.000224	0.00101	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000222	0.000998	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NCOR2—hematologic cancer	0.000221	0.000998	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ABL1—hematologic cancer	0.000217	0.000977	CbGpPWpGaD
Carbimazole—TPO—Metabolism—IDH1—hematologic cancer	0.000211	0.000951	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TXN—hematologic cancer	0.000209	0.00094	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTO1—hematologic cancer	0.000209	0.00094	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCC3—hematologic cancer	0.000209	0.00094	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SPHK1—hematologic cancer	0.000204	0.00092	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—hematologic cancer	0.0002	0.000901	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—hematologic cancer	0.000199	0.000895	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAX—hematologic cancer	0.000199	0.000895	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—hematologic cancer	0.000197	0.000888	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UGT1A1—hematologic cancer	0.000196	0.000884	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—JAK1—hematologic cancer	0.000195	0.000877	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC22A1—hematologic cancer	0.000191	0.00086	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CRABP1—hematologic cancer	0.000191	0.00086	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALOX5—hematologic cancer	0.000186	0.000838	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—hematologic cancer	0.000184	0.000828	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—hematologic cancer	0.000181	0.000816	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000181	0.000814	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NUP98—hematologic cancer	0.00018	0.000812	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADCY7—hematologic cancer	0.000175	0.000788	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NCOA3—hematologic cancer	0.000175	0.000788	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NUP214—hematologic cancer	0.000174	0.000782	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TSC2—hematologic cancer	0.000171	0.000772	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Etoposide—hematologic cancer	0.00017	0.000364	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDK2—hematologic cancer	0.00017	0.000767	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG2—hematologic cancer	0.00017	0.000766	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTR—hematologic cancer	0.00017	0.000766	CbGpPWpGaD
Carbimazole—Eosinophilia—Epirubicin—hematologic cancer	0.00017	0.000362	CcSEcCtD
Carbimazole—Body temperature increased—Vincristine—hematologic cancer	0.00017	0.000362	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—hematologic cancer	0.00017	0.000362	CcSEcCtD
Carbimazole—Skin disorder—Etoposide—hematologic cancer	0.000169	0.000361	CcSEcCtD
Carbimazole—Feeling abnormal—Gemcitabine—hematologic cancer	0.000168	0.000358	CcSEcCtD
Carbimazole—Nausea—Lenalidomide—hematologic cancer	0.000168	0.000358	CcSEcCtD
Carbimazole—TPO—Metabolism—ENO2—hematologic cancer	0.000167	0.000752	CbGpPWpGaD
Carbimazole—Urticaria—Mitoxantrone—hematologic cancer	0.000166	0.000355	CcSEcCtD
Carbimazole—Hypersensitivity—Carmustine—hematologic cancer	0.000166	0.000354	CcSEcCtD
Carbimazole—Pruritus—Thalidomide—hematologic cancer	0.000166	0.000354	CcSEcCtD
Carbimazole—Body temperature increased—Irinotecan—hematologic cancer	0.000165	0.000353	CcSEcCtD
Carbimazole—Body temperature increased—Mitoxantrone—hematologic cancer	0.000165	0.000353	CcSEcCtD
Carbimazole—Nausea—Hydroxyurea—hematologic cancer	0.000165	0.000353	CcSEcCtD
Carbimazole—Myalgia—Triamcinolone—hematologic cancer	0.000165	0.000351	CcSEcCtD
Carbimazole—Hypersensitivity—Alitretinoin—hematologic cancer	0.000164	0.000351	CcSEcCtD
Carbimazole—Rash—Bortezomib—hematologic cancer	0.000164	0.00035	CcSEcCtD
Carbimazole—Dermatitis—Bortezomib—hematologic cancer	0.000164	0.000349	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—hematologic cancer	0.000163	0.000348	CcSEcCtD
Carbimazole—Ill-defined disorder—Dexamethasone—hematologic cancer	0.000163	0.000347	CcSEcCtD
Carbimazole—Ill-defined disorder—Betamethasone—hematologic cancer	0.000163	0.000347	CcSEcCtD
Carbimazole—Headache—Bortezomib—hematologic cancer	0.000163	0.000347	CcSEcCtD
Carbimazole—Discomfort—Triamcinolone—hematologic cancer	0.000163	0.000347	CcSEcCtD
Carbimazole—Rash—Bleomycin—hematologic cancer	0.000163	0.000347	CcSEcCtD
Carbimazole—Dermatitis—Bleomycin—hematologic cancer	0.000162	0.000347	CcSEcCtD
Carbimazole—Hypersensitivity—Ifosfamide—hematologic cancer	0.000162	0.000346	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTT1—hematologic cancer	0.000162	0.000729	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ATM—hematologic cancer	0.000161	0.000728	CbGpPWpGaD
Carbimazole—Body temperature increased—Gemcitabine—hematologic cancer	0.000161	0.000344	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDK4—hematologic cancer	0.000161	0.000724	CbGpPWpGaD
Carbimazole—Neutropenia—Epirubicin—hematologic cancer	0.00016	0.000342	CcSEcCtD
Carbimazole—Angioedema—Dexamethasone—hematologic cancer	0.00016	0.000342	CcSEcCtD
Carbimazole—Angioedema—Betamethasone—hematologic cancer	0.00016	0.000342	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—hematologic cancer	0.00016	0.000721	CbGpPWpGaD
Carbimazole—Rash—Vinorelbine—hematologic cancer	0.00016	0.000341	CcSEcCtD
Carbimazole—Dermatitis—Vinorelbine—hematologic cancer	0.00016	0.000341	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—hematologic cancer	0.000159	0.00034	CcSEcCtD
Carbimazole—Angiopathy—Prednisone—hematologic cancer	0.000159	0.00034	CcSEcCtD
Carbimazole—Headache—Vinorelbine—hematologic cancer	0.000159	0.000339	CcSEcCtD
Carbimazole—Hypersensitivity—Vincristine—hematologic cancer	0.000158	0.000338	CcSEcCtD
Carbimazole—Malaise—Dexamethasone—hematologic cancer	0.000158	0.000338	CcSEcCtD
Carbimazole—Malaise—Betamethasone—hematologic cancer	0.000158	0.000338	CcSEcCtD
Carbimazole—TPO—Metabolism—SDC1—hematologic cancer	0.000158	0.000713	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000158	0.000711	CbGpPWpGaD
Carbimazole—Pruritus—Alitretinoin—hematologic cancer	0.000158	0.000337	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—hematologic cancer	0.000157	0.000335	CcSEcCtD
Carbimazole—Infection—Triamcinolone—hematologic cancer	0.000157	0.000335	CcSEcCtD
Carbimazole—Feeling abnormal—Cisplatin—hematologic cancer	0.000157	0.000334	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAD—hematologic cancer	0.000156	0.000704	CbGpPWpGaD
Carbimazole—Pruritus—Ifosfamide—hematologic cancer	0.000156	0.000333	CcSEcCtD
Carbimazole—Alopecia—Prednisone—hematologic cancer	0.000155	0.000331	CcSEcCtD
Carbimazole—Nausea—Bortezomib—hematologic cancer	0.000154	0.000329	CcSEcCtD
Carbimazole—Hypersensitivity—Irinotecan—hematologic cancer	0.000154	0.000329	CcSEcCtD
Carbimazole—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000154	0.000329	CcSEcCtD
Carbimazole—Nausea—Bleomycin—hematologic cancer	0.000153	0.000327	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—PHYH—hematologic cancer	0.000153	0.00069	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GMPS—hematologic cancer	0.000153	0.00069	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FTCD—hematologic cancer	0.000153	0.00069	CbGpPWpGaD
Carbimazole—Rash—Thiotepa—hematologic cancer	0.000153	0.000326	CcSEcCtD
Carbimazole—Dermatitis—Thiotepa—hematologic cancer	0.000153	0.000326	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—hematologic cancer	0.000153	0.000325	CcSEcCtD
Carbimazole—Headache—Thiotepa—hematologic cancer	0.000152	0.000324	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000152	0.000683	CbGpPWpGaD
Carbimazole—Pancytopenia—Doxorubicin—hematologic cancer	0.000151	0.000322	CcSEcCtD
Carbimazole—Nausea—Vinorelbine—hematologic cancer	0.000151	0.000322	CcSEcCtD
Carbimazole—Body temperature increased—Cisplatin—hematologic cancer	0.00015	0.00032	CcSEcCtD
Carbimazole—Myalgia—Betamethasone—hematologic cancer	0.000149	0.000319	CcSEcCtD
Carbimazole—Myalgia—Dexamethasone—hematologic cancer	0.000149	0.000319	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—hematologic cancer	0.000149	0.000318	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—hematologic cancer	0.000149	0.000318	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—hematologic cancer	0.000148	0.000317	CcSEcCtD
Carbimazole—Rash—Thalidomide—hematologic cancer	0.000148	0.000315	CcSEcCtD
Carbimazole—Discomfort—Betamethasone—hematologic cancer	0.000148	0.000315	CcSEcCtD
Carbimazole—Discomfort—Dexamethasone—hematologic cancer	0.000148	0.000315	CcSEcCtD
Carbimazole—Dermatitis—Thalidomide—hematologic cancer	0.000148	0.000315	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—hematologic cancer	0.000147	0.000315	CcSEcCtD
Carbimazole—Headache—Thalidomide—hematologic cancer	0.000147	0.000313	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—hematologic cancer	0.000147	0.000313	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—hematologic cancer	0.000147	0.000313	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000144	0.000651	CbGpPWpGaD
Carbimazole—Pruritus—Gemcitabine—hematologic cancer	0.000144	0.000308	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CREB1—hematologic cancer	0.000144	0.000649	CbGpPWpGaD
Carbimazole—Nausea—Thiotepa—hematologic cancer	0.000144	0.000307	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000144	0.000307	CcSEcCtD
Carbimazole—Feeling abnormal—Etoposide—hematologic cancer	0.000143	0.000306	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000143	0.000643	CbGpPWpGaD
Carbimazole—Agranulocytosis—Epirubicin—hematologic cancer	0.000143	0.000305	CcSEcCtD
Carbimazole—Infection—Betamethasone—hematologic cancer	0.000142	0.000304	CcSEcCtD
Carbimazole—Infection—Dexamethasone—hematologic cancer	0.000142	0.000304	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—hematologic cancer	0.000142	0.000641	CbGpPWpGaD
Carbimazole—Rash—Carmustine—hematologic cancer	0.000142	0.000303	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisone—hematologic cancer	0.000142	0.000303	CcSEcCtD
Carbimazole—Dermatitis—Carmustine—hematologic cancer	0.000142	0.000303	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisolone—hematologic cancer	0.000141	0.000302	CcSEcCtD
Carbimazole—Headache—Carmustine—hematologic cancer	0.000141	0.000301	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—hematologic cancer	0.000141	0.000635	CbGpPWpGaD
Carbimazole—Rash—Alitretinoin—hematologic cancer	0.000141	0.0003	CcSEcCtD
Carbimazole—Nervous system disorder—Dexamethasone—hematologic cancer	0.00014	0.0003	CcSEcCtD
Carbimazole—Nervous system disorder—Betamethasone—hematologic cancer	0.00014	0.0003	CcSEcCtD
Carbimazole—Dermatitis—Alitretinoin—hematologic cancer	0.00014	0.0003	CcSEcCtD
Carbimazole—Thrombocytopenia—Dexamethasone—hematologic cancer	0.00014	0.000299	CcSEcCtD
Carbimazole—Thrombocytopenia—Betamethasone—hematologic cancer	0.00014	0.000299	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—SMPD3—hematologic cancer	0.00014	0.000631	CbGpPWpGaD
Carbimazole—Hypersensitivity—Cisplatin—hematologic cancer	0.00014	0.000299	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RB1—hematologic cancer	0.00014	0.00063	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.00014	0.00063	CbGpPWpGaD
Carbimazole—Headache—Alitretinoin—hematologic cancer	0.00014	0.000298	CcSEcCtD
Carbimazole—Angioedema—Prednisone—hematologic cancer	0.00014	0.000298	CcSEcCtD
Carbimazole—Nausea—Thalidomide—hematologic cancer	0.000139	0.000297	CcSEcCtD
Carbimazole—Rash—Ifosfamide—hematologic cancer	0.000139	0.000296	CcSEcCtD
Carbimazole—Dermatitis—Ifosfamide—hematologic cancer	0.000139	0.000296	CcSEcCtD
Carbimazole—Urticaria—Etoposide—hematologic cancer	0.000138	0.000295	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—hematologic cancer	0.000138	0.000294	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—hematologic cancer	0.000138	0.000294	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—hematologic cancer	0.000138	0.000294	CcSEcCtD
Carbimazole—Malaise—Prednisone—hematologic cancer	0.000138	0.000294	CcSEcCtD
Carbimazole—Body temperature increased—Etoposide—hematologic cancer	0.000138	0.000294	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—hematologic cancer	0.000137	0.000293	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—hematologic cancer	0.000137	0.000293	CcSEcCtD
Carbimazole—Urticaria—Prednisolone—hematologic cancer	0.000136	0.000291	CcSEcCtD
Carbimazole—Rash—Vincristine—hematologic cancer	0.000135	0.000289	CcSEcCtD
Carbimazole—Dermatitis—Vincristine—hematologic cancer	0.000135	0.000289	CcSEcCtD
Carbimazole—Headache—Vincristine—hematologic cancer	0.000135	0.000287	CcSEcCtD
Carbimazole—TPO—Metabolism—CD44—hematologic cancer	0.000134	0.000606	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NQO1—hematologic cancer	0.000134	0.000606	CbGpPWpGaD
Carbimazole—Nausea—Carmustine—hematologic cancer	0.000134	0.000285	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—hematologic cancer	0.000133	0.000284	CcSEcCtD
Carbimazole—Nausea—Alitretinoin—hematologic cancer	0.000132	0.000283	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—hematologic cancer	0.000132	0.000282	CcSEcCtD
Carbimazole—Rash—Mitoxantrone—hematologic cancer	0.000132	0.000281	CcSEcCtD
Carbimazole—Rash—Irinotecan—hematologic cancer	0.000132	0.000281	CcSEcCtD
Carbimazole—Dermatitis—Mitoxantrone—hematologic cancer	0.000132	0.000281	CcSEcCtD
Carbimazole—Dermatitis—Irinotecan—hematologic cancer	0.000132	0.000281	CcSEcCtD
Carbimazole—Headache—Irinotecan—hematologic cancer	0.000131	0.00028	CcSEcCtD
Carbimazole—Headache—Mitoxantrone—hematologic cancer	0.000131	0.00028	CcSEcCtD
Carbimazole—Nausea—Ifosfamide—hematologic cancer	0.000131	0.000279	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.000131	0.000588	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.00013	0.000278	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.00013	0.000278	CcSEcCtD
Carbimazole—Myalgia—Prednisone—hematologic cancer	0.00013	0.000278	CcSEcCtD
Carbimazole—Arthralgia—Prednisone—hematologic cancer	0.00013	0.000278	CcSEcCtD
Carbimazole—Feeling abnormal—Triamcinolone—hematologic cancer	0.00013	0.000278	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—hematologic cancer	0.00013	0.000277	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000129	0.000276	CcSEcCtD
Carbimazole—Discomfort—Prednisone—hematologic cancer	0.000129	0.000274	CcSEcCtD
Carbimazole—Rash—Gemcitabine—hematologic cancer	0.000128	0.000274	CcSEcCtD
Carbimazole—Dermatitis—Gemcitabine—hematologic cancer	0.000128	0.000274	CcSEcCtD
Carbimazole—Hypersensitivity—Etoposide—hematologic cancer	0.000128	0.000274	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—hematologic cancer	0.000128	0.000272	CcSEcCtD
Carbimazole—Headache—Gemcitabine—hematologic cancer	0.000128	0.000272	CcSEcCtD
Carbimazole—Nausea—Vincristine—hematologic cancer	0.000128	0.000272	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.000127	0.000573	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYCS—hematologic cancer	0.000127	0.000573	CbGpPWpGaD
Carbimazole—Hepatitis—Doxorubicin—hematologic cancer	0.000127	0.000271	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—hematologic cancer	0.000127	0.000271	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisolone—hematologic cancer	0.000126	0.00027	CcSEcCtD
Carbimazole—TPO—Metabolism—HSP90AA1—hematologic cancer	0.000126	0.00057	CbGpPWpGaD
Carbimazole—Urticaria—Triamcinolone—hematologic cancer	0.000125	0.000268	CcSEcCtD
Carbimazole—Body temperature increased—Triamcinolone—hematologic cancer	0.000125	0.000266	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—hematologic cancer	0.000125	0.000266	CcSEcCtD
Carbimazole—Nausea—Mitoxantrone—hematologic cancer	0.000124	0.000265	CcSEcCtD
Carbimazole—Nausea—Irinotecan—hematologic cancer	0.000124	0.000265	CcSEcCtD
Carbimazole—Infection—Prednisone—hematologic cancer	0.000124	0.000264	CcSEcCtD
Carbimazole—Pruritus—Etoposide—hematologic cancer	0.000123	0.000263	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—DCK—hematologic cancer	0.000122	0.000552	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ASNS—hematologic cancer	0.000122	0.000552	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—B3GAT1—hematologic cancer	0.000122	0.000552	CbGpPWpGaD
Carbimazole—Nervous system disorder—Prednisone—hematologic cancer	0.000122	0.000261	CcSEcCtD
Carbimazole—Alopecia—Epirubicin—hematologic cancer	0.000121	0.000259	CcSEcCtD
Carbimazole—Skin disorder—Prednisone—hematologic cancer	0.000121	0.000259	CcSEcCtD
Carbimazole—Nausea—Gemcitabine—hematologic cancer	0.000121	0.000258	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	0.000121	0.000545	CbGpPWpGaD
Carbimazole—Rash—Cisplatin—hematologic cancer	0.00012	0.000256	CcSEcCtD
Carbimazole—Dermatitis—Cisplatin—hematologic cancer	0.00012	0.000255	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.00012	0.000539	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	0.000119	0.000537	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Methotrexate—hematologic cancer	0.000118	0.000253	CcSEcCtD
Carbimazole—Feeling abnormal—Dexamethasone—hematologic cancer	0.000118	0.000252	CcSEcCtD
Carbimazole—Feeling abnormal—Betamethasone—hematologic cancer	0.000118	0.000252	CcSEcCtD
Carbimazole—Hypersensitivity—Triamcinolone—hematologic cancer	0.000116	0.000248	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—HDC—hematologic cancer	0.000116	0.000523	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	0.000116	0.000523	CbGpPWpGaD
Carbimazole—Angiopathy—Doxorubicin—hematologic cancer	0.000115	0.000246	CcSEcCtD
Carbimazole—Malaise—Methotrexate—hematologic cancer	0.000115	0.000246	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—hematologic cancer	0.000114	0.000244	CcSEcCtD
Carbimazole—Urticaria—Betamethasone—hematologic cancer	0.000114	0.000243	CcSEcCtD
Carbimazole—Urticaria—Dexamethasone—hematologic cancer	0.000114	0.000243	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000114	0.000242	CcSEcCtD
Carbimazole—Body temperature increased—Betamethasone—hematologic cancer	0.000113	0.000242	CcSEcCtD
Carbimazole—Body temperature increased—Dexamethasone—hematologic cancer	0.000113	0.000242	CcSEcCtD
Carbimazole—Nausea—Cisplatin—hematologic cancer	0.000113	0.000241	CcSEcCtD
Carbimazole—Alopecia—Doxorubicin—hematologic cancer	0.000112	0.00024	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTP1—hematologic cancer	0.000112	0.000505	CbGpPWpGaD
Carbimazole—Pruritus—Triamcinolone—hematologic cancer	0.000112	0.000238	CcSEcCtD
Carbimazole—Ill-defined disorder—Epirubicin—hematologic cancer	0.000111	0.000237	CcSEcCtD
Carbimazole—Rash—Etoposide—hematologic cancer	0.00011	0.000234	CcSEcCtD
Carbimazole—Dermatitis—Etoposide—hematologic cancer	0.00011	0.000234	CcSEcCtD
Carbimazole—Headache—Etoposide—hematologic cancer	0.000109	0.000233	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—hematologic cancer	0.000109	0.000232	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—hematologic cancer	0.000109	0.000232	CcSEcCtD
Carbimazole—Rash—Prednisolone—hematologic cancer	0.000108	0.000231	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000108	0.000488	CbGpPWpGaD
Carbimazole—Dermatitis—Prednisolone—hematologic cancer	0.000108	0.000231	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000108	0.00023	CcSEcCtD
Carbimazole—Malaise—Epirubicin—hematologic cancer	0.000108	0.00023	CcSEcCtD
Carbimazole—Headache—Prednisolone—hematologic cancer	0.000108	0.000229	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—hematologic cancer	0.000107	0.000229	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—hematologic cancer	0.000107	0.000228	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	0.000107	0.000481	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCB1—hematologic cancer	0.000106	0.000478	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CDA—hematologic cancer	0.000106	0.000478	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	0.000104	0.000468	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—hematologic cancer	0.000104	0.000467	CbGpPWpGaD
Carbimazole—Infection—Methotrexate—hematologic cancer	0.000104	0.000221	CcSEcCtD
Carbimazole—Nausea—Etoposide—hematologic cancer	0.000103	0.000221	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOR1—hematologic cancer	0.000103	0.000464	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—hematologic cancer	0.000103	0.000464	CbGpPWpGaD
Carbimazole—Feeling abnormal—Prednisone—hematologic cancer	0.000103	0.000219	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—hematologic cancer	0.000103	0.000219	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—hematologic cancer	0.000102	0.000218	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—PC—hematologic cancer	0.000102	0.00046	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Methotrexate—hematologic cancer	0.000102	0.000218	CcSEcCtD
Carbimazole—Nausea—Prednisolone—hematologic cancer	0.000102	0.000218	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—hematologic cancer	0.000102	0.000217	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—hematologic cancer	0.000102	0.000217	CcSEcCtD
Carbimazole—Pruritus—Dexamethasone—hematologic cancer	0.000101	0.000216	CcSEcCtD
Carbimazole—Pruritus—Betamethasone—hematologic cancer	0.000101	0.000216	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—hematologic cancer	0.000101	0.000216	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000101	0.000216	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—hematologic cancer	0.000101	0.000215	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	0.0001	0.000452	CbGpPWpGaD
Carbimazole—Malaise—Doxorubicin—hematologic cancer	9.97e-05	0.000213	CcSEcCtD
Carbimazole—Rash—Triamcinolone—hematologic cancer	9.95e-05	0.000212	CcSEcCtD
Carbimazole—Dermatitis—Triamcinolone—hematologic cancer	9.94e-05	0.000212	CcSEcCtD
Carbimazole—Urticaria—Prednisone—hematologic cancer	9.91e-05	0.000211	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—hematologic cancer	9.9e-05	0.000211	CcSEcCtD
Carbimazole—Headache—Triamcinolone—hematologic cancer	9.89e-05	0.000211	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—GBA—hematologic cancer	9.87e-05	0.000445	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC35B2—hematologic cancer	9.87e-05	0.000445	CbGpPWpGaD
Carbimazole—Body temperature increased—Prednisone—hematologic cancer	9.86e-05	0.00021	CcSEcCtD
Carbimazole—Infection—Epirubicin—hematologic cancer	9.69e-05	0.000207	CcSEcCtD
Carbimazole—Nervous system disorder—Epirubicin—hematologic cancer	9.57e-05	0.000204	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EP300—hematologic cancer	9.56e-05	0.000431	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Epirubicin—hematologic cancer	9.55e-05	0.000204	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—hematologic cancer	9.5e-05	0.000203	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—hematologic cancer	9.47e-05	0.000202	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—hematologic cancer	9.42e-05	0.000201	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—hematologic cancer	9.42e-05	0.000201	CcSEcCtD
Carbimazole—Nausea—Triamcinolone—hematologic cancer	9.38e-05	0.0002	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	9.35e-05	0.0002	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—hematologic cancer	9.3e-05	0.000199	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisone—hematologic cancer	9.19e-05	0.000196	CcSEcCtD
Carbimazole—TPO—Metabolism—MTHFR—hematologic cancer	9.11e-05	0.00041	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	9.05e-05	0.000408	CbGpPWpGaD
Carbimazole—Rash—Betamethasone—hematologic cancer	9.03e-05	0.000193	CcSEcCtD
Carbimazole—Rash—Dexamethasone—hematologic cancer	9.03e-05	0.000193	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—MTAP—hematologic cancer	9.02e-05	0.000407	CbGpPWpGaD
Carbimazole—Dermatitis—Dexamethasone—hematologic cancer	9.02e-05	0.000193	CcSEcCtD
Carbimazole—Dermatitis—Betamethasone—hematologic cancer	9.02e-05	0.000193	CcSEcCtD
Carbimazole—Headache—Betamethasone—hematologic cancer	8.97e-05	0.000191	CcSEcCtD
Carbimazole—Headache—Dexamethasone—hematologic cancer	8.97e-05	0.000191	CcSEcCtD
Carbimazole—Infection—Doxorubicin—hematologic cancer	8.97e-05	0.000191	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.89e-05	0.00019	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—hematologic cancer	8.85e-05	0.000189	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—hematologic cancer	8.84e-05	0.000189	CcSEcCtD
Carbimazole—Pruritus—Prednisone—hematologic cancer	8.82e-05	0.000188	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—hematologic cancer	8.77e-05	0.000187	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—hematologic cancer	8.59e-05	0.000183	CcSEcCtD
Carbimazole—Nausea—Dexamethasone—hematologic cancer	8.51e-05	0.000182	CcSEcCtD
Carbimazole—Nausea—Betamethasone—hematologic cancer	8.51e-05	0.000182	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—hematologic cancer	8.33e-05	0.000375	CbGpPWpGaD
Carbimazole—Urticaria—Methotrexate—hematologic cancer	8.28e-05	0.000177	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—hematologic cancer	8.24e-05	0.000176	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	8.22e-05	0.000175	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—FHL2—hematologic cancer	8.04e-05	0.000362	CbGpPWpGaD
Carbimazole—Feeling abnormal—Epirubicin—hematologic cancer	8.04e-05	0.000172	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—AGRN—hematologic cancer	7.89e-05	0.000355	CbGpPWpGaD
Carbimazole—Rash—Prednisone—hematologic cancer	7.86e-05	0.000168	CcSEcCtD
Carbimazole—Dermatitis—Prednisone—hematologic cancer	7.86e-05	0.000168	CcSEcCtD
Carbimazole—Headache—Prednisone—hematologic cancer	7.81e-05	0.000167	CcSEcCtD
Carbimazole—Urticaria—Epirubicin—hematologic cancer	7.75e-05	0.000165	CcSEcCtD
Carbimazole—Body temperature increased—Epirubicin—hematologic cancer	7.71e-05	0.000165	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	7.69e-05	0.000347	CbGpPWpGaD
Carbimazole—Hypersensitivity—Methotrexate—hematologic cancer	7.68e-05	0.000164	CcSEcCtD
Carbimazole—TPO—Metabolism—PIK3CG—hematologic cancer	7.65e-05	0.000345	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMMR—hematologic cancer	7.48e-05	0.000337	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—IDH2—hematologic cancer	7.48e-05	0.000337	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—hematologic cancer	7.44e-05	0.000159	CcSEcCtD
Carbimazole—Nausea—Prednisone—hematologic cancer	7.41e-05	0.000158	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—hematologic cancer	7.37e-05	0.000157	CcSEcCtD
Carbimazole—Hypersensitivity—Epirubicin—hematologic cancer	7.19e-05	0.000153	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—hematologic cancer	7.17e-05	0.000153	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—hematologic cancer	7.13e-05	0.000152	CcSEcCtD
Carbimazole—TPO—Metabolism—CREBBP—hematologic cancer	7.09e-05	0.00032	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.05e-05	0.000318	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ARNTL—hematologic cancer	7.03e-05	0.000317	CbGpPWpGaD
Carbimazole—Pruritus—Epirubicin—hematologic cancer	6.9e-05	0.000147	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—CA9—hematologic cancer	6.84e-05	0.000308	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACP5—hematologic cancer	6.84e-05	0.000308	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—hematologic cancer	6.84e-05	0.000308	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOR2—hematologic cancer	6.75e-05	0.000304	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—hematologic cancer	6.73e-05	0.000303	CbGpPWpGaD
Carbimazole—Hypersensitivity—Doxorubicin—hematologic cancer	6.65e-05	0.000142	CcSEcCtD
Carbimazole—TPO—Metabolism—ALB—hematologic cancer	6.64e-05	0.000299	CbGpPWpGaD
Carbimazole—Rash—Methotrexate—hematologic cancer	6.57e-05	0.00014	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—hematologic cancer	6.57e-05	0.00014	CcSEcCtD
Carbimazole—Headache—Methotrexate—hematologic cancer	6.53e-05	0.000139	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—IDH1—hematologic cancer	6.43e-05	0.00029	CbGpPWpGaD
Carbimazole—Pruritus—Doxorubicin—hematologic cancer	6.39e-05	0.000136	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—GSTO1—hematologic cancer	6.36e-05	0.000287	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCC3—hematologic cancer	6.36e-05	0.000287	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TXN—hematologic cancer	6.36e-05	0.000287	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3R1—hematologic cancer	6.35e-05	0.000286	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SPHK1—hematologic cancer	6.22e-05	0.00028	CbGpPWpGaD
Carbimazole—Nausea—Methotrexate—hematologic cancer	6.19e-05	0.000132	CcSEcCtD
Carbimazole—Rash—Epirubicin—hematologic cancer	6.15e-05	0.000131	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—hematologic cancer	6.14e-05	0.000131	CcSEcCtD
Carbimazole—Headache—Epirubicin—hematologic cancer	6.11e-05	0.00013	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—UGT1A1—hematologic cancer	5.98e-05	0.000269	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—hematologic cancer	5.86e-05	0.000264	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC22A1—hematologic cancer	5.82e-05	0.000262	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CRABP1—hematologic cancer	5.82e-05	0.000262	CbGpPWpGaD
Carbimazole—Nausea—Epirubicin—hematologic cancer	5.79e-05	0.000124	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	5.77e-05	0.00026	CbGpPWpGaD
Carbimazole—Rash—Doxorubicin—hematologic cancer	5.69e-05	0.000121	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—hematologic cancer	5.69e-05	0.000121	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—ALOX5—hematologic cancer	5.67e-05	0.000255	CbGpPWpGaD
Carbimazole—Headache—Doxorubicin—hematologic cancer	5.65e-05	0.000121	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—NUP98—hematologic cancer	5.49e-05	0.000247	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—hematologic cancer	5.36e-05	0.000114	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—ADCY7—hematologic cancer	5.33e-05	0.00024	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA3—hematologic cancer	5.33e-05	0.00024	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NUP214—hematologic cancer	5.29e-05	0.000238	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.24e-05	0.000236	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTR—hematologic cancer	5.18e-05	0.000234	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG2—hematologic cancer	5.18e-05	0.000234	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ENO2—hematologic cancer	5.08e-05	0.000229	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—hematologic cancer	5.07e-05	0.000228	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—hematologic cancer	4.93e-05	0.000222	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.85e-05	0.000219	CbGpPWpGaD
Carbimazole—TPO—Metabolism—EP300—hematologic cancer	4.83e-05	0.000218	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SDC1—hematologic cancer	4.82e-05	0.000217	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.6e-05	0.000207	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.54e-05	0.000205	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.35e-05	0.000196	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NQO1—hematologic cancer	4.1e-05	0.000185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CD44—hematologic cancer	4.1e-05	0.000185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.01e-05	0.000181	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYCS—hematologic cancer	3.88e-05	0.000175	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSP90AA1—hematologic cancer	3.85e-05	0.000174	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—hematologic cancer	3.57e-05	0.000161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.47e-05	0.000156	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—hematologic cancer	3.42e-05	0.000154	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.31e-05	0.000149	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCB1—hematologic cancer	3.23e-05	0.000146	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOR1—hematologic cancer	3.14e-05	0.000142	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—hematologic cancer	3.14e-05	0.000142	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—hematologic cancer	2.92e-05	0.000132	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—hematologic cancer	2.78e-05	0.000125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.45e-05	0.00011	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—hematologic cancer	2.33e-05	0.000105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CREBBP—hematologic cancer	2.16e-05	9.74e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—hematologic cancer	2.05e-05	9.24e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—hematologic cancer	2.02e-05	9.12e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3R1—hematologic cancer	1.94e-05	8.72e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—hematologic cancer	1.79e-05	8.05e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—hematologic cancer	1.54e-05	6.96e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—EP300—hematologic cancer	1.47e-05	6.64e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—hematologic cancer	1.09e-05	4.91e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—hematologic cancer	8.9e-06	4.01e-05	CbGpPWpGaD
